RYMA SANTIAGO: Open Payments
NPI 1245814128 · GURNEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,311 in 239 payments from 20 companies in 2025. Trend: 2023 $8,907 · 2024 $13,165 · 2025 $7,311
Food & beverage: $3,950Speaker / faculty: $2,700Travel & lodging: $576Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 23 | $3,604 |
| Janssen Biotech, Inc. | 74 | $1,217 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $468 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $431 |
| PFIZER INC. | 25 | $409 |
| ABBVIE INC. | 23 | $290 |
| Madrigal Pharmaceuticals | 7 | $245 |
| Phathom Pharmaceuticals, Inc. | 11 | $158 |
| Ardelyx, Inc. | 12 | $142 |
| Ipsen Biopharmaceuticals, Inc | 2 | $64 |
Products named: OMVOH, TREMFYA, XIFAXAN, XELJANZ, ENTYVIO, REZDIFFRA, VOQUEZNA, IBSRELA.
Industry payments across IL — which companies pay providers there.
